Effect of Rasagiline on BIA 9-1067 Pharmacokinetics

NCT01532141 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: BIA 9-1067
DRUG: Rasagiline

Sponsor

Bial - Portela C S.A.